PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.231
https://www.valueinhealthjournal.com/article/S1098-3015(18)33531-9/fulltext
Title : PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33531-9&doi=10.1016/j.jval.2018.09.231
First page :
Section Title :
Open access? : No
Section Order : 1668
Categories :
Tags :
Regions :
ViH Article Tags :